Multaq - Investigational Agent for the Treatment of Cardiac Arrhythmia
Key Data:
Drug (Brand/Generic)
Multaq (dronedarone hydrochloride)
Company/Licensee
Sanofi-Aventis
Therapy Class
Class III antiarryhthmic
Product Description
Amiodarone analogue
Current Indication
Prevention of recurrence of AF
Market Sector
Cardiovascular
Development Status
Approved in the US and Canada
